Interim Report 1 January 2020 – 30 September 2020
Scandion Oncology A/S (”Scandion Oncology” or “the Company”) hereby publishes the Interim Report for the period 1 January – 30 September 2020. The Interim Report is available on the Company's website (www.scandiononcology.com). Below is a summary of the report.Reporting period July 2020 – September 2020 · Net sales amounted to DKK 0 (0). · Operating profit was -4.90 m DKK (-7.03). · Cash and bank assets amounted to 7.50 m DKK (18.03). · Result per share was DKK -0.20 (-0.33). Reporting period January 2020 – September 2020 · Net sales amounted to DKK 0 (0). ·